1-1 of 1
Julie L. Sutcliff, PhD
Close
Sort by
Journal Articles

Intravenous, Intraperitoneal, and Subcutaneous Routes of Administering 64 Cu-DOTA-HB22.7 Display Equivalent Tumor Targeting Ability.

Shiloh M. Martin, MD, Robert T. O’Donnell, M.D., Hayes McKnight, Julie L. Sutcliff, PhD, Joseph M. Tuscano, M.D.
Journal: Blood
Blood (2007) 110 (11): 2359.
https://doi.org/10.1182/blood.V110.11.2359.2359
Published: 2007